Company Filing History:
3 out of 55 
2 out of 38 
2 out of 67 
Years Active: 2021-2025
Title: Muriel Pichavant: Innovator in Monoclonal Antibodies for COPD Treatment
Introduction
Muriel Pichavant is a prominent inventor based in Lille, France. She has made significant contributions to the field of medical research, particularly in the development of monoclonal antibodies aimed at treating chronic obstructive pulmonary disease (COPD). With a total of 3 patents, her work addresses critical health challenges faced by patients suffering from this debilitating condition.
Latest Patents
One of her latest patents focuses on monoclonal antibodies specific for IL20-Rb, which are designed to treat bacterial-induced exacerbations of COPD. This invention is particularly important as acute exacerbations of COPD are often caused by respiratory infections, leading to a decline in lung function and increased inflammation. The patent outlines methods for generating antibodies that can effectively neutralize IL-20Rb, thereby improving bacterial clearance and reducing inflammation in affected patients. Another patent relates to pharmaceutical compositions and methods for treating acute exacerbations of COPD through the antagonism of IL-20 cytokines, providing a therapeutic approach for patients in need.
Career Highlights
Throughout her career, Muriel Pichavant has worked with esteemed institutions such as Inserm (Institut National de la Santé et de la Recherche Médicale) and Institut Pasteur de Lille. Her research has been pivotal in advancing our understanding of COPD and developing innovative treatments that can enhance patient outcomes.
Collaborations
Muriel has collaborated with notable colleagues in her field, including Philippe Gosset and Magdiel Perez-Cruz. These partnerships have contributed to the success of her research and the development of her patents.
Conclusion
Muriel Pichavant's work in the field of monoclonal antibodies represents a significant advancement in the treatment of chronic obstructive pulmonary disease. Her innovative patents and collaborations highlight her dedication to improving healthcare outcomes for patients worldwide.